XML 35 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenues (Tables)
 3 Months Ended
Mar. 29, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
Revenues consisted of the following (in thousands):
Three Months Ended March 31,
20242023
Product revenues:
Gross product revenues$563,785 $521,322 
Discounts and allowances(185,262)(157,922)
Net product revenues378,523 363,400 
Collaboration revenues:
License revenues44,676 38,292 
Collaboration services revenues2,027 7,096 
Total collaboration revenues46,703 45,388 
Total revenues$425,226 $408,788 
Net product revenues by product were as follows (in thousands):
Three Months Ended March 31,
20242023
CABOMETYX$376,417 $361,773 
COMETRIQ2,106 1,627 
Net product revenues$378,523 $363,400 
Schedule of Concentration Risks
The percentage of total revenues by customer who individually accounted for 10% or more of our total revenues were as follows:
Three Months Ended March 31,
20242023
Affiliates of AmerisourceBergen Corporation19 %17 %
Affiliates of McKesson Corporation18 %17 %
Affiliates of CVS Health Corporation17 %17 %
Accredo Health, Incorporated12 %12 %
Affiliates of Optum Specialty Pharmacy10 %10 %
The percentage of trade receivables by customer who individually accounted for 10% or more of our trade receivables were as follows:
March 31, 2024December 31, 2023
Affiliates of McKesson Corporation26 %21 %
Affiliates of AmerisourceBergen Corporation20 %17 %
Ipsen Pharma SAS19 %19 %
Affiliates of CVS Health Corporation15 %20 %
Cardinal Health, Inc.10 %11 %
Schedule of Revenues Disaggregated by Geographic Region
Total revenues by geographic region were as follows (in thousands):
Three Months Ended March 31,
20242023
U.S.$381,937 $367,441 
Europe35,703 33,534 
Japan7,586 7,813 
Total revenues$425,226 $408,788 
Schedule of Activities and Ending Reserve Balances for Significant Categories of Discounts and Allowances
The activities and ending reserve balances for each significant category of discounts and allowances (which constitute variable consideration) were as follows (in thousands):
Chargebacks, Discounts for Prompt Payment and Other
Other Customer Credits/Fees and Co-pay Assistance
Rebates
Total
Balance at December 31, 2023
$25,221 $19,721 $39,898 $84,840 
Provision related to sales made in:
Current period115,134 17,725 54,093 186,952 
Prior periods(625)(1,162)97 (1,690)
Payments and customer credits issued(111,424)(17,768)(36,953)(166,145)
Balance at March 31, 2024
$28,306 $18,516 $57,135 $103,957 
Schedule of Other Assets and Other Liabilities
Contract assets and liabilities were as follows (in thousands):
March 31, 2024December 31, 2023
Contract assets (1)
$1,343 $1,321 
Contract liabilities:
Current portion (2)
$4,054 $5,406 
Long-term portion (3)
4,922 5,524 
Total contract liabilities$8,976 $10,930 
____________________
(1)     Presented in other long-term assets in the accompanying Condensed Consolidated Balance Sheets.
(2)     Presented in other current liabilities in the accompanying Condensed Consolidated Balance Sheets.
(3)     Presented in other long-term liabilities in the accompanying Condensed Consolidated Balance Sheets.